Delivery Order SPE2DB25D7056-SPE2DB25FTLVJ

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,046.54 firm fixed-price delivery order is for the supply of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of October 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with the ID SPE2DB24D1007|SPE2DB25FCACK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a ceiling value of $1,019.56. The ultimate completion date...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,265.49 firm fixed-price delivery order is for the supply of FOCALIN XR CAPS 10MG, a medication used to treat attention-deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. AmerisourceBergen holds a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,715.18 firm fixed-price delivery order is for the supply of Focalin XR 10 mg capsules, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has an ultimate completion date of December 7, 2023 and was awarded on December 6, 2022. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.50 firm-fixed-price delivery order is for the supply of Focalin XR Capsules, 20mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $3,065.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR 30 mg capsules, a medication commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a...
This federal contract award, valued at $4,186.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Focalin XR 5 mg capsules, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a period of performance running through February 14, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DX22D0010|SPE2D824FMD57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $18,826.00 firm-fixed-price delivery order is for the supply of Focalin XR capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,380.69 firm-fixed-price delivery order is for the supply of Focalin XR 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award, valued at $3,152.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Focalin XR 25 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a period of performance ending on November 30, 2023. This award is not designated as a set-aside...
  • SPE2DB25D7056
    Indefinite Delivery Contract
  • SPE2DB25D7056-SPE2DB25FTLVJ
    Delivery Order

This federal contract award, with the ID SPE2DB25D7056|SPE2DB25FTLVJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The $2,692.47 firm-fixed-price delivery order is for the supply of 4566921649 Focalin XR 5 mg capsules, a medication used to treat attention-deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order award is likely part of that larger IDC contract. No set-aside designation was used for this specific award.

Generated 4/16/25, 5:45 PM